FDA Approves Next-Generation Flu Vaccine for Adults Over 50

Washington, Sunday, 23 August 2026. The FDA has approved Moderna’s first mRNA flu vaccine for adults over 50, offering 27% greater protection than traditional shots while enabling significantly faster production against mutating seasonal strains.